GenetiKit Workshop Given by: Dr. Sean Blaine, Family Physician Dr. June Carroll, Family Physician Clare Gibbons, Genetic Counsellor Cathy Gilpin, Genetic.

Slides:



Advertisements
Similar presentations
What Do We Do? Cancer Genetics Service for Wales.
Advertisements

Hereditary GI Cancer Syndromes: Keys to identify high risk patients
Which of the following increases a women’s risk for Breast Cancer? A.Starting her menses at age 14 or older B.Breastfeeding C.Extremely dense breast tissue.
Medical Genomics Promise, Peril and Price. Alison J Whelan M.D., FACP Professor of Medicine and Pediatrics Director of the Hereditary Cancer Clinic Washington.
Breast MR Imaging Workshop th September 2014 High-Risk Screening Evidence-based Clinical Indications for Breast MRI Dr. Muhamad Zabidi Ahmad, AMDI.
Princess Alexandra Hospitals NHS Trust Breast Unit Family History Clinic.
USPSTF Screening Recommendations: Implications for Adults at Higher Risk NYFAHC Roundtable, June 18, 2013 Robert A. Smith, PhD Senior Director, Cancer.
10 November 2011 Genetic counseling for breast cancer risk Aichu Huang, MS. CGC. Department of Medical Genetics National Taiwan University Hospital.
Familial Cancer Risk Assessment: Breast and Ovarian Cancer Genetics and Primary Care.
Alzheimer disease Developed by Dr. June Carroll, Ms. Shawna Morrison and Dr. Judith Allanson Last updated April 2015.
Hereditary Factors in Breast Cancer
The Genetics of Breast and Ovarian Cancer Susceptibility Patricia Tonin, PhD Associate Professor Depts. Medicine, Human Genetics & Oncology McGill University.
Genetics and Ovarian Cancer Jeanne M. Schilder, M.D. Associate Professor, Gynecologic Oncology Indiana University Medical Center September 19, 2012.
© 2001 Myriad Genetic Laboratories Northern Nevada Genetic Counseling Robbin Palmer Certified Genetic Counselor
Hereditary Breast & Ovarian Cancer Syndrome HBOC Tammy McKamie RN MSN OCN Cancer Genetics Educator Clinical Oncology Patient Navigator.
Breast Cancer Risk and Risk Assessment Models
Cancer Genetics for Primary Care Sara Levene Registered Genetic Counsellor.
The Harvard Health Caucus Genetic Privacy: Legal & Ethical Frameworks Allan T. Bombard, MD, FACOG, FACS, FACMG Medical Director, Aetna Women’s Health Program.
Genetic Testing in Genomic Medicine Gail H. Vance M.D. Professor, Department of Medical & Molecular Genetics Indiana University School of Medicine.
Genetic Testing for Hereditary Cancer Susceptibility
Rochelle Shoretz Founder and Executive Director Culturally Appropriate Health Communications For Women At Increased Risk.
OVARIAN CANCER Talking point: Genetics of ovarian cancer.
Role of clinical genetics in medicine. Who provides this service Varies depending on structure and funding of service but is in reality provided by many.
Breast Screening. NHS Breast Screening Programme Introduced in 1988 Invites women from age group for screening every 3 yrs. Age extension roll-out.
Genetics & Colorectal Cancer
The Cancer Pedigree BRCA What?. Outline Introduction: Understanding the weight of genetics in Ovarian Breast Cancer BRCA 1 and BRCA 2 Genes – Function.
Genetics and Ovarian Cancer June 16, 2015 Ovarian Cancer Alliance of Oregon and SW Washington Becky Clark, MS, CGC Genetic Counselor.
Genomics Alexandra Hayes. Genomics is the study of all the genes in a person, as well as the interactions of those genes with each other and a person’s.
Corrine Fillman, M.S., C.G.C. Connective Tissue Gene Tests (CTGT) 6580 Snowdrift Road, Suite 300 Allentown, PA
GENETIC TESTING: WHAT DOES IT REALLY TELL YOU? Lori L. Ballinger, MS, CGC Licensed Genetic Counselor University of New Mexico Cancer Center.
Cancer Risk Assessment Judith A Westman MD Clinical Director Division of Human Genetics.
Chapter 13 Carrier Screening. Introduction Carrier screening involves testing of individuals for heterozygosity for genes that would produce significant.
Alzheimer’s Disease Tessa Dillon Nova Southeastern University Clinical Genetics Teri Doolittle, PA-C, MHP, DHSc August 3, 2008.
Adult-Onset Disease The Example of Colon Cancer Summer, 2012.
Shiva Sharma SHO to Professor Redmond.  Introduction  Increased risk groups  Consideration of genetic testing  Management of patients with mutation.
Familial cancer syndromes: Tools that can help connect the dots in primary care Emily Edelman, MS, CGC NCHPEG Cancer in the family: Primary Care Matters.
Breast Cancer and Ethical Issues Regarding Insurance Coverage! By Jenn Butt Heidi Keefe Melissa Snyder Rachel Malinowski.
Genetics: For this Generation and the Next
Breast Cancer Prevention Art or Science? Kristi McIntyre M.D. Texas Oncology 2005.
Hereditary Breast and Ovarian Cancer Syndrome
Private pay, physician ordered genetic testing Developed by Dr. Judith Allanson, Ms. Shawna Morrison and Dr. June Carroll Last updated November 2015.
Understanding Genetic Testing
Alzheimer disease Developed by Dr. June Carroll, Ms. Shawna Morrison and Dr. Judith Allanson Last updated Dec 2014.
Cancer 101: A Cancer Education and Training Program for [Target Population] Date Location Presented by: Presenter 1 Presenter 2.
What is a Gene? Genetic information is key Top 5 Reasons to Know Your Family History 5. Family recipes should be kept secret — family medical history.
Identifying and Managing Hereditary Cancer Syndromes © 2005 Myriad Genetic Laboratories, Inc. Monica Trout, MS Genetic Counselor / Regional Medical Specialist.
What Percentage of Cancer is Considered to be Hereditary?
What did I inherit from my parents? Today’s Objectives: Review basic genetic concepts Create family health tree Identify patterns suggesting genetic link.
Genetic Counseling Yahwardiah Siregar Sry Suryani W Mutiara Indah Sari.
Genomic Medicine Rebecca Tay Oncology Registrar. What is Genomic Medicine? personalised, precision or stratified medicine.
The National Cancer Research Network is part of the National Institute for Health Research CANCER GENETIC TRIALS Leicestershire, Northamptonshire and Rutland.
Hereditary Breast and Ovarian Cancer Syndrome Developed by Ms. Shawna Morrison, Dr. June Carroll, and Dr. Judith Allanson Last updated May 2016.
1 Copyright © 2012 by Mosby, an imprint of Elsevier Inc. Copyright © 2008 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 11 Genomics in Public Health.
Date of download: 7/7/2016 From: Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility: Systematic Evidence Review.
Refer to Beds & Herts Breast Cancer Family History Screening service
Hereditary Cancer Predisposition: Updates in Genetic Testing
Pathways involved in hereditary breast cancer
Kristen Zarfos, MD Linda Steinmark, MS, LCGC
Nancy Anoja, MSc, CCGC Genetic counsellor
Introduction
Kyle Salsbery Genetic Counselor
Demystifying Cancer Genetics

Who in the room would offer BRCA1/2 testing to this patient Who in the room would offer BRCA1/2 testing to this patient? How might the medical management.
Refer to Beds & Herts Breast Cancer Family History Screening service
Genetics and Breast Cancer Adelphi 2018 Educational Forum Sharona Cohen, MS, CGC Certified Genetic Counselor Northwell Health.
Lynch syndrome (LS) Hereditary Non-polyposis Colorectal Cancer (HNPCC)
Genetic Cancer Screening
Genetic Cancer Screening Medicare Insurance Clients
Family History to Promote Individual Health
Presentation transcript:

GenetiKit Workshop Given by: Dr. Sean Blaine, Family Physician Dr. June Carroll, Family Physician Clare Gibbons, Genetic Counsellor Cathy Gilpin, Genetic Counsellor Funded by CIHR

2 GenetiKit Project  Purpose:  To help family physicians think “genetically”  To increase knowledge about genetic testing for common disorders  To give family physicians a framework for assessing the usefulness of new genetic tests Funded by CIHR

3 GenetiKit Project Protocol Step 1: Questionnaire #1 – already completed Step 2: Workshop  Introduce tools to help integrate genetics into practice - case example Step 3: Use project tools over next 6 months Step 4: Questionnaire #2  $250 to compensate for your time at completion of Q2 We want to see:  What you think of our project materials  Do they help you in practice? Please do not share this information with your colleagues

4  Why is genetics important?  Case example  GenetiKit tools  Study protocol  Gene Messenger  GenetiKit Web site Workshop Outline

5  By 2010:  Predictive genetic tests for a dozen common conditions  “$1000 genome sequencing test”  No longer only the domain of geneticists and genetic counsellors Genomic medicine will change medical practice

6 The Promise of Genetics:  Prediction of risk of disease  Individualized screening, surveillance, and prevention  Safer and more effective drug therapy  Individualized environmental risk factor assessment

7 The reality – Is this “genohype”?  Genetic testing available for very few common adult onset hereditary diseases  Gene-environment interaction responsible for most common diseases  Lack of evidence for effective interventions

8 Why should family physicians know about genetics?  Common diseases  Public interest  Media coverage of genetic testing  Direct marketing of genetic testing  Patients will turn to family physicians for information and advice

FP’s patients asked: Where would you go for more information about genetic testing? Carroll, Blaine et al 2002 Unpublished data

10 What Makes Genetic Testing for Adult-Onset Diseases Different from Other Types of Testing?  Uncertainty  Will the condition develop?  When?  How severe?  Will interventions make a difference?  Direct implications for family members  Ethical, legal and social issues

11 Case Example - Breast Cancer  35 year old investment banker  asked her busy family doctor to refer her for genetic testing  history of breast cancer in grandmother  has heard of BRCA testing  looked at Myriad website  would like genetic testing…..

12 Maternal family history 32 David A&W 35 PATIENT A&W Breast Ca Dx 72 Breast Legend 60 Irene A&W 58 Jean ↑ Chol Michael Jason A&W 76 d. MI 63 George HTN

13

Family history assessment Breast Legend

15 Family history assessment Breast Legend

16 Family history assessment Breast Legend

17

18 Ontario Physician’s Guide to Referral of Patients with a Family History of Cancer to a Familial Cancer Genetics Clinic or Genetics Clinic Sources:  MOH 2002 Bulletin gram/ohip/bulletins/4000/bul4381.html  Ontario Medical Review (Nov 2001)

21 Let’s continue the case….

22 Pearls – Red flags for hereditary disorders  Multiple affected relatives  More than 1 generation affected  Closely related  Early age of onset

23 Who should be offered referral for genetic counselling and/or genetic testing?  Multiple cases of breast and/or ovarian cancer in family  closely related relatives  more than one generation  Br Ca diagnosed at < age 50  Breast cancer diagnosed at age < 35  Family member with both breast and ovarian cancers  Ashkenazi Jewish + relatives with breast or ovarian cancer

24 Who should be offered referral for genetic counselling and/or genetic testing?…  Family member with primary cancer in both breasts  especially if diagnosed < age 50  Family member with invasive serous ovarian cancer  Male breast cancer  Family member with an identified BRCA1 or BRCA2 mutation

25 Adding paternal family history 32 David A&W 35 PATIENT A&W Breast Ca Dx Irene A&W 58 Jean ↑ Chol Michael Jason A&W 76 d. MI 63 George HTN Ovarian Ca Dx ? Bilateral Breast Ca Dx ? Breast Ovarian Legend

26 32 David A&W 35 PATIENT A&W Breast Ca Dx Irene A&W 58 Jean ↑ Chol Michael Jason A&W 76 d. MI 63 George HTN Ovarian Ca Dx ? Bilateral Breast Ca Dx ? Breast Ovarian Legend Diabetes Paternal family history

27 32 David A&W 35 PATIENT A&W Breast Ca Dx Irene A&W 58 Jean ↑ Chol Michael Jason A&W 76 d. MI 63 George HTN d. 57 Ovarian Ca Dx 56 Breast Ovarian Legend Diabetes Bilateral Breast Ca Dx 45 Dx ? A&W d. 70’s Breast Ca Dx 69 90’s A&W Paternal family history

28

29 Breast Ovarian Legend 32 David A&W 35 PATIENT A&W Breast Ca Dx Irene A&W 58 Jean ↑ Chol Michael Jason A&W 76 d. MI 63 George HTN Ovarian Ca Dx 56 Diabetes Bilateral Breast Ca Dx 45 Dx ? A&W 90’s A&W d. 70’s Breast Ca Dx 69 Family history

30

31 Family history assessment Breast Ovarian Legend

32 bb BbBb BbBb BbBb Breast Cancer Affected with breast cancer Autosomal Dominant Inheritance Population Risk Population Risk Susceptible BRCA gene Unaffected Legend B: BRCA gene with mutation b: normal BRCA gene

33 Consequences of having a BRCA mutation Estimated Risk in BRCA Mutation Carriers – by Age 70 In General Population Breast Cancer ♀ %11% Ovarian Cancer BRCA %1-2% Ovarian Cancer BRCA %1-2% Breast Cancer ♂ BRCA2 6%<1%

34 Breast Ovarian Legend 32 David A&W 35 PATIENT A&W Breast Ca Dx Irene A&W 58 Jean ↑ Chol Michael Jason A&W 76 d. MI 63 George HTN Ovarian Ca Dx 56 Diabetes Bilateral Breast Ca Dx 45 Dx ? A&W 90’s A&W d. 70’s Breast Ca Dx 69 Family history

35 Possible Genetic Testing Results

36 Possible Genetic Testing Results

37 Possible Genetic Testing Results

38 Possible Genetic Testing Results

39 What are the benefits / harms of genetic testing for hereditary breast/ovarian cancer?

40 BENEFITS - Mutation Present  Disease Causing Mutation Present  Gene mutation predicted to cause or increase risk for disease  Clinical Benefit  Clear basis for existing clinical interventions that improve outcome  “OK, so I have the gene, what should I do to protect myself and stay healthy?”

41 BENEFITS - Mutation Absent  Clear Negative Genetic Test Result  Absence of a known gene mutation previously identified in the family  Emotional Benefit  Relief from worry about disease risk  “Thank goodness I don’t have it!”

42 Benefits

43 HARMS – Mutation Present  Disease Causing Mutation Present Socio-legal Harms  Insurance premiums may be increased  Other Harms Fear!  Patient may become fatalistic towards health  Other family members may become distressed on patient’s or their own behalf

44 HARMS – Mutation Present  Variant of Unknown Significance  Emotional harm Uncertainty  What does the mutation really mean? How to handle it?  Remember they are still at high risk on the basis of their family history, so the clinical interventions apply and may carry their own risks

45 HARMS – Mutation Absent  Clear Negative gene test result  Emotional harm Survivor Guilt  Cannot identify with the disease group  No excuse for life problems

46 HARMS - Mutation Absent  Uninformative Test Result  Health Behaviour Harm  Complacency  Fatalism towards health  Still need to follow clinical recommendations as family history risk still present

47 Harms

48 What can be done for BRCA Mutation Carriers to reduce the risk of breast/ovarian cancer? Surgical options - Bilateral risk-reducing mastectomy - Bilateral risk-reducing oophorectomy - 90% risk reduction in high-risk women - hazard ratio for br ca = hazard ratio for ovarian ca = 0.04 Chemoprevention -Tamoxifen - raloxifene, aromatase inhibitors - shows promise in BRCA2 carriers - under study

49 Genetics clinical pathway  Pattern – is it genetic?  Known gene mutation(s) for disorder?  Evidence for gene mutation = disorder?  What proportion of people with the disorder have the gene mutation?  Can we change disease incidence?  Can we change disease outcome?

50 Genetic Clinic Resources  Talk to your local genetics clinic  Check whether referral appropriate  Update on new genetic tests or advancements  Contact information in package

51 Family Physician’s Role in Genetics  Take a family history  Assess risk  Refer to genetics  Discuss benefits and harms of genetic testing  Provide emotional support  Coordinate prevention and management

52 GenetiKit Tools  Hereditary breast/ovarian cancer triage/management card + patient booklet and web site  Hereditary crc triage/management card  Pearls  Ontario Guidelines for referral and testing for hereditary breast/ovarian and colorectal cancer  Family History Tool  Consequences tool  Gene Messenger  Contact sheet for genetic clinic referrals

53

54 Gene Messenger  To suggest topics, us at: 

55 GenetiKit Web Site Password: genetics

56 Please fill in the workshop evaluation Thank you. Questions?